Breast Cancer Clinical Trial
Inspiratory Muscle Training in Obese Breast Cancer Survivors
Summary
The investigators propose a randomized controlled trial to determine the effectiveness of inspiratory muscle training in improving exercise tolerance among stage 0-III obese breast cancer survivors.
Full Description
The proposed study has two parts:
Randomized controlled trial (RCT) where obese participants (N=133) are randomized to three arms: [i] IMT 4 wks + IMT&Exercise 12 wks, [ii] IMT 4 wks + Exercise 12 wks, [iii] SHAM 4 wks + Exercise 12 wks).
Cross-sectional trial where nonobese participants (N=50) will be recruited to assess differences in exercise tolerance and its underlying physiological mechanisms between obese and nonobese participants.
Only the RCT part involves random assignment of participants and the clinical trial.
Eligibility Criteria
Inclusion Criteria:
completed active treatment for a Stage 0-III breast cancer diagnosis within 6 months to 5 years of enrollment.
obese as defined by a body mass index (BMI) of 30 to 50 kg/m2 & nonobese as defined as BMI 18.5 to 24.9 kg/m2
patients who are on adjuvant endocrine therapy will be allowed to participate.
sedentary (participating in less than 90 min of moderate intensity activity per week) and have at least one limitation in activity on the 10-question RAND-36 Physical Function Subscale to ensure some exercise intolerance
Exclusion Criteria:
functional limitations that make independent exercise unsafe
current smokers
metastatic breast cancer
ongoing or active infection with recent antibiotics or steroids
heart disease precluding exercise (congestive heart failure, unstable angina pectoris, cardiac arrhythmia)
psychiatric illness/social situations that would limit compliance with study requirements
orthopedic or neuromuscular disorders or arthritis that preclude participation in exercise
unwilling or unable to follow protocol requirements
pregnant or nursing
any condition which in the investigator's opinion deems the subject an unsuitable candidate to participate in this study
presence of provokable ECG changes suggestive of heart disease, or dangerous arrhythmias or exercise induced hypertension, etc. during the cardiopulmonary exercise test
non-English speaking
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Columbus Ohio, 43210, United States More Info
Principal Investigator
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.